ZHENG Liangzhen
Co-founder/CTO
Dr. ZHENG Liangzhen is the Co-founder and Chief Technology Officer of Orchidlinn. He holds a B.S. in Biotechnology from Wuhan University and a Ph.D. in Computational Biology from Nanyang Technological University.
As a core developer of OnionNet, Dr. ZHENG has demonstrated his technical expertise and innovation. He is an iGEM gold medalist, showcasing his prowess in synthetic biology and biotechnology. Dr. ZHENG has also achieved top rankings in prestigious competitions like Continuous Automated Model Evaluation (CAMEO) and Critical Assessment of Structure Prediction (CASP) 14 (2020) and 15 (2022), further cementing his reputation as a leading computational biologist.
Dr. ZHENG’s research accomplishments are equally impressive. He has authored over 20 publications that have been cited more than 550 times in journals such as ‘Nature Machine Intelligence’. His work has made significant contributions to advancing the field of computational biology.
With his strong academic credentials, technical acumen, and research achievements, Dr. ZHENG is a driving force behind the company's technological innovations and its mission to push the boundaries of biotechnology.
As a core developer of OnionNet, Dr. ZHENG has demonstrated his technical expertise and innovation. He is an iGEM gold medalist, showcasing his prowess in synthetic biology and biotechnology. Dr. ZHENG has also achieved top rankings in prestigious competitions like Continuous Automated Model Evaluation (CAMEO) and Critical Assessment of Structure Prediction (CASP) 14 (2020) and 15 (2022), further cementing his reputation as a leading computational biologist.
Dr. ZHENG’s research accomplishments are equally impressive. He has authored over 20 publications that have been cited more than 550 times in journals such as ‘Nature Machine Intelligence’. His work has made significant contributions to advancing the field of computational biology.
With his strong academic credentials, technical acumen, and research achievements, Dr. ZHENG is a driving force behind the company's technological innovations and its mission to push the boundaries of biotechnology.